Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $14.10 billion. The enterprise value is $24.89 billion.
| Market Cap | 14.10B |
| Enterprise Value | 24.89B |
Important Dates
The next estimated earnings date is Tuesday, July 21, 2026, before market open.
| Earnings Date | Jul 21, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 86.14 million shares outstanding. The number of shares has decreased by -7.78% in one year.
| Current Share Class | 86.14M |
| Shares Outstanding | 86.14M |
| Shares Change (YoY) | -7.78% |
| Shares Change (QoQ) | -0.37% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 97.44% |
| Float | 85.13M |
Valuation Ratios
The trailing PE ratio is 8.55 and the forward PE ratio is 9.34. THC's PEG ratio is 1.40.
| PE Ratio | 8.55 |
| Forward PE | 9.34 |
| PS Ratio | 0.68 |
| Forward PS | 1.33 |
| PB Ratio | 3.04 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.37 |
| P/OCF Ratio | 3.36 |
| PEG Ratio | 1.40 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.37, with an EV/FCF ratio of 7.43.
| EV / Earnings | 14.62 |
| EV / Sales | 1.16 |
| EV / EBITDA | 5.37 |
| EV / EBIT | 6.64 |
| EV / FCF | 7.43 |
Financial Position
The company has a current ratio of 1.36, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.36 |
| Quick Ratio | 1.13 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 2.62 |
| Debt / FCF | 3.94 |
| Interest Coverage | 4.56 |
Financial Efficiency
Return on equity (ROE) is 30.29% and return on invested capital (ROIC) is 15.85%.
| Return on Equity (ROE) | 30.29% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 15.85% |
| Return on Capital Employed (ROCE) | 14.97% |
| Weighted Average Cost of Capital (WACC) | 8.46% |
| Revenue Per Employee | $216,717 |
| Profits Per Employee | $17,202 |
| Employee Count | 99,000 |
| Asset Turnover | 0.71 |
| Inventory Turnover | 36.69 |
Taxes
In the past 12 months, THC has paid $516.00 million in taxes.
| Income Tax | 516.00M |
| Effective Tax Rate | 16.29% |
Stock Price Statistics
The stock price has decreased by -2.27% in the last 52 weeks. The beta is 1.30, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -2.27% |
| 50-Day Moving Average | 188.66 |
| 200-Day Moving Average | 199.35 |
| Relative Strength Index (RSI) | 32.22 |
| Average Volume (20 Days) | 1,388,529 |
Short Selling Information
The latest short interest is 2.50 million, so 2.90% of the outstanding shares have been sold short.
| Short Interest | 2.50M |
| Short Previous Month | 2.40M |
| Short % of Shares Out | 2.90% |
| Short % of Float | 2.93% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
In the last 12 months, THC had revenue of $21.46 billion and earned $1.70 billion in profits. Earnings per share was $19.14.
| Revenue | 21.46B |
| Gross Profit | 8.85B |
| Operating Income | 3.75B |
| Pretax Income | 3.17B |
| Net Income | 1.70B |
| EBITDA | 4.64B |
| EBIT | 3.75B |
| Earnings Per Share (EPS) | $19.14 |
Balance Sheet
The company has $2.97 billion in cash and $13.21 billion in debt, with a net cash position of -$10.24 billion or -$118.90 per share.
| Cash & Cash Equivalents | 2.97B |
| Total Debt | 13.21B |
| Net Cash | -10.24B |
| Net Cash Per Share | -$118.90 |
| Equity (Book Value) | 8.85B |
| Book Value Per Share | 55.90 |
| Working Capital | 2.20B |
Cash Flow
In the last 12 months, operating cash flow was $4.37 billion and capital expenditures -$1.02 billion, giving a free cash flow of $3.35 billion.
| Operating Cash Flow | 4.37B |
| Capital Expenditures | -1.02B |
| Depreciation & Amortization | 886.00M |
| Net Borrowing | -84.00M |
| Free Cash Flow | 3.35B |
| FCF Per Share | $38.88 |
Margins
Gross margin is 41.26%, with operating and profit margins of 17.47% and 7.94%.
| Gross Margin | 41.26% |
| Operating Margin | 17.47% |
| Pretax Margin | 14.76% |
| Profit Margin | 7.94% |
| EBITDA Margin | 21.60% |
| EBIT Margin | 17.47% |
| FCF Margin | 15.61% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 7.78% |
| Shareholder Yield | 7.78% |
| Earnings Yield | 11.62% |
| FCF Yield | 22.86% |
Analyst Forecast
The average price target for THC is $244.57, which is 49.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $244.57 |
| Price Target Difference | 49.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 22 |
| Revenue Growth Forecast (3Y) | 3.37% |
| EPS Growth Forecast (3Y) | 3.41% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 1.84 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.84 |
| Piotroski F-Score | 6 |